Pramipexole augmentation for the acute phase of treatment-resistant, unipolar depression: a placebo-controlled, double-blind, randomised trial in the UK.
Browning M, Cowen PJ, Galal U, Baldwin A, Cleare AJ, Evans J, Huys QJM, Kessler D, Kurkar M, Nixon N, Rastogi A, Watson S, Yu LM, Mort S, Simon J, Laszewska A, Lewis AC, Roberts SM, Fiske V, Frending LM, Money C, Godlewska BR, Ryland HT, Halahakoon DC, Wright LA, Salas B, Peddada A, Wahba M, Taylor KS, Kerr-Gaffney J, Swiffen D, Zangani C, Smith KA, Harmer CJ, Geddes JR; PAX-D study group.
Browning M, et al. Among authors: lewis ac.
Lancet Psychiatry. 2025 Jun 27:S2215-0366(25)00194-4. doi: 10.1016/S2215-0366(25)00194-4. Online ahead of print.
Lancet Psychiatry. 2025.
PMID: 40602411